Hair Loss
Hair-loss care may involve FDA-approved, off-label, or compounded options depending on the clinical situation and treatment plan.
Product type varies by plan
Some uses are off-label or compounded
Eligibility determined by clinician
Provider-guided options
Hair-loss plans may include FDA-approved, off-label, or compounded approaches. This page emphasizes consultation pathways rather than a shelf of interchangeable products.
Treatment pathways in this category are reviewed case by case. Contact support if you would like to discuss current availability with the care team.
How these options are considered
A clinician reviews hair-loss pattern, medical history, and product-specific considerations before determining whether any option is appropriate. Product type and risk profile vary across the category.
Product type varies by plan
- Hair-loss care may involve FDA-approved, off-label, or compounded options depending on the product and patient.
- Oral minoxidil for hair loss is off-label, and there is no FDA-approved topical finasteride product.